A detailed history of Sage Private Wealth Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sage Private Wealth Group, LLC holds 1,124 shares of ABBV stock, worth $226,688. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,124
Previous 1,123 0.09%
Holding current value
$226,688
Previous $172,000 12.21%
% of portfolio
0.2%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $134 - $153
1 Added 0.09%
1,124 $151,000
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $8,807 - $11,197
64 Added 6.04%
1,123 $172,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $10,426 - $12,936
79 Added 8.06%
1,059 $172,000
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $9,346 - $11,825
87 Added 9.74%
980 $132,000
Q4 2020

Mar 02, 2021

BUY
$80.49 - $108.67 $71,877 - $97,042
893 New
893 $96,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sage Private Wealth Group, LLC Portfolio

Follow Sage Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Private Wealth Group, LLC with notifications on news.